Find comprehensive information on pituitary adenoma diagnosis, including clinical documentation, medical coding (ICD-10 codes D35.2), healthcare guidelines, and treatment options. Learn about pituitary tumor symptoms, diagnostic testing, and the latest research on pituitary disorders. Explore resources for healthcare professionals, including coding best practices and clinical documentation improvement for accurate pituitary adenoma diagnosis reporting. This resource provides valuable information for patients and clinicians seeking information on pituitary adenomas.
Also known as
Benign neoplasm of pituitary gland
Covers benign pituitary tumors, including most adenomas.
Acromegaly and gigantism
Relates to pituitary adenomas overproducing growth hormone.
Cushing's syndrome
May be caused by pituitary adenomas secreting ACTH.
Neoplasm of uncertain behavior of pituitary
Used for adenomas where benign or malignant status is unclear.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the pituitary adenoma functional (hormone-secreting)?
Yes
Which hormone is primarily secreted?
No
Is there evidence of pituitary apoplexy?
Coding error due to unspecified functional vs. non-functional adenoma (e.g., prolactinoma) impacting DRG assignment and reimbursement.
Failure to document size (>10mm) leading to undercoding and lost revenue. Important for accurate quality reporting.
Discrepancy between clinical documentation and coded diagnosis (e.g., incidentaloma vs. symptomatic) affecting data integrity and analysis.
Patient presents with symptoms suggestive of pituitary adenoma, including [specific symptoms e.g., headaches, visual disturbances such as bitemporal hemianopsia, amenorrhea galactorrhea, acromegaly, Cushing's disease symptoms if applicable]. On physical examination, [relevant findings e.g., visual field deficits, signs of hormonal excess or deficiency]. Differential diagnosis includes other sellar and parasellar lesions, such as craniopharyngioma, meningioma, and Rathke's cleft cyst. Biochemical evaluation revealed [hormonal levels e.g., elevated prolactin, growth hormone, ACTH, or decreased FSH, LH, TSH]. MRI of the brain with pituitary protocol demonstrated a [size and characteristics of adenoma e.g., 1.5 cm x 1.0 cm homogenous enhancing lesion within the sella turcica, with suprasellar extension]. Given the clinical presentation, imaging findings, and laboratory results, the diagnosis of pituitary adenoma is established. Treatment options discussed include medical management with [specific medications if applicable e.g., dopamine agonists, somatostatin analogs], surgical resection via transsphenoidal approach, and radiation therapy. Risks and benefits of each treatment modality were explained to the patient. The patient will follow up for repeat imaging and hormonal evaluation to monitor treatment response. ICD-10 code D35.2 is assigned. CPT codes for services rendered will be documented separately. Further evaluation and management will be based on the patient's clinical course and response to therapy.